TABLE 2.
C. dubliniensis and C. albicans clinical isolates
Species and country of isolation | No. of isolatesa | Specimen | HIV status of subjects sampled | Reference or source |
---|---|---|---|---|
C. dubliniensis | ||||
Argentina | 1 | Oral cavity | + | 23 |
Australia | 5 | Oral cavity | + | 10, 25 |
Belgium | 5 | Oral cavity | + | 14 |
Canada | 6 | Oral cavity | + | 14 |
Finland | 1 | Oral cavity | + | 14 |
Germany | 4 | Oral cavity | + | 14 |
Greece | 1 | Oral cavity | + | 14 |
Ireland | 23 | Oral cavity | + | 4, 25 |
Ireland | 4 | Oral cavity | − | 4 |
Ireland | 4 | Vaginal | − | 11, 14 |
Spain | 10 | Oral cavity | + | 14, this study |
Switzerland | 6 | Oral cavity | + | 2, 23 |
United Kingdom | 2 | Oral cavity | + | 14, 23 |
United Kingdom | 7 | Oral cavity | − | 14 |
United Kingdom | 4 | Miscellaneousb | − | 14, 23 |
Total | 83 | |||
C. albicans | ||||
Australia | 1 | Oral cavity | + | 25 |
Hong Kong | 6 | Oral cavity | + | 14 |
Ireland | 12 | Oral cavity | + | 14 |
16 | Oral cavity | − | 14 | |
United Kingdom | 9 | Oral cavity | − | 14 |
Total | 44 |
Each isolate was recovered from a separate individual.
These included one isolate each from a blood culture and fecal, sputum, and postmortem lung specimens.